Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
Franziska Haderk(Boehringer Ingelheim (Germany)), Trever G. Bivona(University of California, San Francisco)
Cited by 84
Related Papers
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Targeting Oncogenic BRAF: Past, Present, and Future
|Cancers|2019|241
Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma
|Nature Communications|2020|161